The PI3K/Akt/mTOR pathway has been reported to be overexpressed in nearly 50% of hepatocellular carcinomas, and it plays a crucial role in tumorigenesis and progression [51]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.